Named Patient Program (NPP) in Egypt
How the named patient program (npp) pathway operates in Egypt.
About Named Patient Program (NPP)
The foundational pathway for providing individual patients access to drugs not yet registered in their country.
How Named Patient Program (NPP) works in Egypt
Egypt's EDA permits personal-use import of non-registered drugs under physician supervision; process is paperwork-heavy but viable.
Patients in Egypt seeking access under Named Patient Program (NPP) typically follow this flow: a licensed physician in Egypt issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.
Documents required in Egypt
- Physician prescription and clinical-justification letter.
- Patient identification and consent.
- Country-specific NPP/personal-import form.
- Hospital or clinic attestation where required.
Typical timeline
End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.